Cannabis Use, Neurobiology, Psychology, and Treatment
Herausgeber: R Martin, Colin; Preedy, Victor R; Patel, Vinood B
Cannabis Use, Neurobiology, Psychology, and Treatment
Herausgeber: R Martin, Colin; Preedy, Victor R; Patel, Vinood B
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Cannabis Use, Neurobiology, Psychology, and Treatment offers readers a comprehensive reference on neurological changes, both transient and long-term, and other factors surrounding the use of these compounds and extracts. With coverage of both natural and synthetic cannabinoids, this broad coverage allows readers to learn about both adverse and non-adverse effects, including reactivity to pain, changes in behavior, and neuroactivity. This volume provides a platform for research on the effects of these compounds in brain function and neurological dysfunction. Extracts from the Cannabis sativa…mehr
Andere Kunden interessierten sich auch für
![Medicinal Usage of Cannabis and Cannabinoids]( "Medicinal Usage of Cannabis and Cannabinoids")
Medicinal Usage of Cannabis and Cannabinoids205,99 €![Neurobiology and Physiology of the Endocannabinoid System]( "Neurobiology and Physiology of the Endocannabinoid System")
Neurobiology and Physiology of the Endocannabinoid System205,99 €![Diagnosis and Treatment of Spinal Cord Injury]( "Diagnosis and Treatment of Spinal Cord Injury")
Diagnosis and Treatment of Spinal Cord Injury205,99 €![Genetics, Neurology, Behavior, and Diet in Dementia]( "Genetics, Neurology, Behavior, and Diet in Dementia")
Genetics, Neurology, Behavior, and Diet in Dementia164,99 €![Genetics, Neurology, Behavior, and Diet in Parkinson's Disease]( "Genetics, Neurology, Behavior, and Diet in Parkinson's Disease")
Genetics, Neurology, Behavior, and Diet in Parkinson's Disease164,99 €![Cellular, Molecular, Physiological, and Behavioral Aspects of Spinal Cord Injury]( "Cellular, Molecular, Physiological, and Behavioral Aspects of Spinal Cord Injury")
Cellular, Molecular, Physiological, and Behavioral Aspects of Spinal Cord Injury205,99 €![Cellular, Molecular, Physiological, and Behavioral Aspects of Traumatic Brain Injury]( "Cellular, Molecular, Physiological, and Behavioral Aspects of Traumatic Brain Injury")
Cellular, Molecular, Physiological, and Behavioral Aspects of Traumatic Brain Injury205,99 €-
-
-
Cannabis Use, Neurobiology, Psychology, and Treatment offers readers a comprehensive reference on neurological changes, both transient and long-term, and other factors surrounding the use of these compounds and extracts. With coverage of both natural and synthetic cannabinoids, this broad coverage allows readers to learn about both adverse and non-adverse effects, including reactivity to pain, changes in behavior, and neuroactivity. This volume provides a platform for research on the effects of these compounds in brain function and neurological dysfunction. Extracts from the Cannabis sativa plant contain scores of psychoactive compounds in addition to the principal agent tetrahydrocannabinol, many of which are neuroactive.
Produktdetails
- Produktdetails
- Verlag: Elsevier Health Sciences
- Seitenzahl: 670
- Erscheinungstermin: 6. Juli 2023
- Englisch
- Abmessung: 276mm x 216mm
- Gewicht: 1970g
- ISBN-13: 9780323898621
- ISBN-10: 0323898629
- Artikelnr.: 66278255
- Verlag: Elsevier Health Sciences
- Seitenzahl: 670
- Erscheinungstermin: 6. Juli 2023
- Englisch
- Abmessung: 276mm x 216mm
- Gewicht: 1970g
- ISBN-13: 9780323898621
- ISBN-10: 0323898629
- Artikelnr.: 66278255
Preface
I. Setting the scene and introductory chapters
1. Metabolomics of the cannabis plant Mickel Hiebert-Giesbrecht, Claudia
Torres-Calzada and David Scott Wishart
2. The roots of Cannabis sativa: chemical and pharmacological profile L A.
Rolim
3. Cannabis related compounds in beverages and food Ilaria Di Marco
Pisciottano
4. The impact of prenatal cannabis exposure: an overview Natalia Kleinhans
5. Cannabis Genotoxicity and Cancer Incidence: Highly Concordant Synthesis
of European and USA Datasets Albert Stuart Reece and Gary K. Hulse
6. Cannabis Genotoxicity and Cancer Incidence: A Highly Concordant
Synthesis of European and USA Datasets Albert Stuart Reece and Gary K.
Hulse
7. Cannabis, Cognitive impairment and Car Crash risk U.W. Preuss
II. Cannabis usage
8. Recreational cannabis use: a French perspective of adverse effects
Emilie Bouquet, Emilie Jouanjus and Maryse Lapeyre-Mestre
9. Acute and chronic impact of cannabis on human cognition Justin Matheson
and Bernard Le Foll
10. Polydrug users, use of cannabidiol (CBD) and abuse potential/Polydrug
users, use of cannabinoids and abuse potential Kerri Alexandra Schoedel
11. Cannabis stigmas: a narrative of features Matt Reid
12. Alterations of THC and CBD ratios and impact on cognition Erica
Zamberletti
13. When cannabis is used for medicinal purposes: a focus on back pain R.
L. Price III
III. Pharmacological and Physiological Aspects
14. Cannabis, cannabinoids and receptor responses Yi Yang, Roya Derwish and
Lakshmi P. Kotra
15. Cannabidiol (CBD): abuse potential and withdrawal Kenneth W.
Sommerville and Beatrice Setnik
16. 4,5- Dihydro-1H-pyrazole/3,4-Diarylpyrazoline class of cannabinoid-1
(CB1R) receptor antagonists and their potential in medicinal applications
Malliga R. Iyer
IV. Neurobiology of cannabis
17. Neurobiology of cannabis Rohit Goyal and Deepak Kumar
18. The kynurenine pathway, neurobiology and cannabis misuse: a new
narrative Nuria Morales-Puerto and Esther O'Shea
19. Central nervous system cancers and use of cannabis and related
products: an updated narrative J. Eduardo Rodriguez Almaraz and Nicholas
Butowski
20. Chronic cannabis users: links with glutamate and resting state
connectivity S.D. Newman
21. Brain metabolic responses to cannabis use in people with multiple
sclerosis: Insights from [18F]-FDG positron emission tomography and
functional MRI Thorsten Rudroff
22. Genetic Variation and Acute Responses to Cannabis Bernard Le Foll, Zoe
Bourgault and Justin Matheson
23. Cell Signaling of the CB1 Cannabinoid Receptor via beta-arrestins,
Cannabinoid Receptor Interacting Protein (CRIP1a) and other regulatory
proteins Allyn C. Howlett
24. Cannabis and impact on memory: from in utero to adults Jennifer
Willford, Meaghan Hazelet, Mohamad Khalaifa, Natacha DeGenna and Gale A.
Richardson
25. Central CB1 receptors and age-related changes: investigating the
effects of DELTA-9-tetrahydrocannabinol Brett C. Ginsburg and Hanana
AlTfaili
26. Alcohol, cannabis and visual memory Concepcion Vinader-Caerols
V. Neurobiology of cannabinoids
27. The role of Delta-FosB in the plasticity of the cannabinoid system
Arturo Venebra-Munoz and Sara Mejía-Chávez
28. Functional profile of synthetic cannabinoid receptor agonists:
exploring cannabinoid and non-cannabinoid targets Shivani Sachdev, Marina
Santiago and Chris Bladen
29. Linking the G protein-coupled orphan receptor GPR55 to the cannabinoid
receptors (CB1 and CB2): a new narrative Paula Morales, Raquel
Guerrero-Alba and B.A. Marichal-Cancino
30. Proteomic analysis of cannabinoids in human oligodendrocytes Valéria
Almeida
31. Cannabinoids and endocannabinoid signaling at the basal forebrain
cholinergic system Rafael Rodriguez
32. Cannabidiol (The major non-psychotropic cannabinoid in the cannabis
plant) and the PI3K/Akt pathway in the CNS Nadja Schroder
33. Effects of cannabidiol and other phytocannabinoids on ion channels
Murat Oz, Keun-Hang Susan Yang, Mohamed Mahgoub, Georg Petroianu and
Dietrich Lorke
34. Cannabis, neurodevelopment and the "two-hit hypothesis" Elisa Guma,
Lani Cupo and Mallar Chakravarty
VI. New and synthetic cannabinoids
35. Impact of tetrahydrocannabinol (THC ) and synthetic "spice"cannabinoids
on nicotine use and abuse Christie Dawn Fowler and Angeline Dukes
36. Synthetic cannabinoids: how do they compare to
DELTA9-tetrahydrocannabinol: neurological effects and beyond Chris S.
Breivogel
VII. Biomarkers, analysis and screening
37. The DSM-5 criteria of cannabis use disorder: methods and applications
Mahadev Sen, Siddharth Sarkar and Yesh Singh
38. Cannabis and clinical high risk for psychosis: monitoring and
smartphones Jean Addington
VIII. Impact on non-neurological systems
39. The impact of cannabis and cannabinoids on the skin Jane M. Grant-Kels
40. Cannabis consumption in reproduction and teratogenicity Susana Sa and
B.M. Fonseca
41. Cannabis compounds and putative cytotoxicity: profile of cancer cells
Hadar Peeri and Hinanit Koltai
IX. Treatments, strategies and resources
42. Motivational Interviewing for Cannabis Use Disorders: a narrative
review from research to practice Hugo López-Pelayo, Maria Teresa
Pons-Cabrera, Clara Oliveras Salvà and Pablo Rodrigo Guzmán Cortez
43. An Overview of Current Pharmacologic Interventions for Management of
Cannabis Withdrawal and the Evidence for Their Use David Wolinsky
44. Managing cannabinoid hyperemesis syndrome in paediatrics: A new
narrative review Justin P. Reinert
45. Gabapentinoids for the Treatment of Cannabis Use Disorder: A Focus on
Human Laboratory Research Joshua A. Lile
46. Treating psychosis in users of synthetic cannabinoids T. Klimenko and
Svetlana Shakhova
X. Resources
47. Cannabis and Web based Resources Rajkumar Rajendram
I. Setting the scene and introductory chapters
1. Metabolomics of the cannabis plant Mickel Hiebert-Giesbrecht, Claudia
Torres-Calzada and David Scott Wishart
2. The roots of Cannabis sativa: chemical and pharmacological profile L A.
Rolim
3. Cannabis related compounds in beverages and food Ilaria Di Marco
Pisciottano
4. The impact of prenatal cannabis exposure: an overview Natalia Kleinhans
5. Cannabis Genotoxicity and Cancer Incidence: Highly Concordant Synthesis
of European and USA Datasets Albert Stuart Reece and Gary K. Hulse
6. Cannabis Genotoxicity and Cancer Incidence: A Highly Concordant
Synthesis of European and USA Datasets Albert Stuart Reece and Gary K.
Hulse
7. Cannabis, Cognitive impairment and Car Crash risk U.W. Preuss
II. Cannabis usage
8. Recreational cannabis use: a French perspective of adverse effects
Emilie Bouquet, Emilie Jouanjus and Maryse Lapeyre-Mestre
9. Acute and chronic impact of cannabis on human cognition Justin Matheson
and Bernard Le Foll
10. Polydrug users, use of cannabidiol (CBD) and abuse potential/Polydrug
users, use of cannabinoids and abuse potential Kerri Alexandra Schoedel
11. Cannabis stigmas: a narrative of features Matt Reid
12. Alterations of THC and CBD ratios and impact on cognition Erica
Zamberletti
13. When cannabis is used for medicinal purposes: a focus on back pain R.
L. Price III
III. Pharmacological and Physiological Aspects
14. Cannabis, cannabinoids and receptor responses Yi Yang, Roya Derwish and
Lakshmi P. Kotra
15. Cannabidiol (CBD): abuse potential and withdrawal Kenneth W.
Sommerville and Beatrice Setnik
16. 4,5- Dihydro-1H-pyrazole/3,4-Diarylpyrazoline class of cannabinoid-1
(CB1R) receptor antagonists and their potential in medicinal applications
Malliga R. Iyer
IV. Neurobiology of cannabis
17. Neurobiology of cannabis Rohit Goyal and Deepak Kumar
18. The kynurenine pathway, neurobiology and cannabis misuse: a new
narrative Nuria Morales-Puerto and Esther O'Shea
19. Central nervous system cancers and use of cannabis and related
products: an updated narrative J. Eduardo Rodriguez Almaraz and Nicholas
Butowski
20. Chronic cannabis users: links with glutamate and resting state
connectivity S.D. Newman
21. Brain metabolic responses to cannabis use in people with multiple
sclerosis: Insights from [18F]-FDG positron emission tomography and
functional MRI Thorsten Rudroff
22. Genetic Variation and Acute Responses to Cannabis Bernard Le Foll, Zoe
Bourgault and Justin Matheson
23. Cell Signaling of the CB1 Cannabinoid Receptor via beta-arrestins,
Cannabinoid Receptor Interacting Protein (CRIP1a) and other regulatory
proteins Allyn C. Howlett
24. Cannabis and impact on memory: from in utero to adults Jennifer
Willford, Meaghan Hazelet, Mohamad Khalaifa, Natacha DeGenna and Gale A.
Richardson
25. Central CB1 receptors and age-related changes: investigating the
effects of DELTA-9-tetrahydrocannabinol Brett C. Ginsburg and Hanana
AlTfaili
26. Alcohol, cannabis and visual memory Concepcion Vinader-Caerols
V. Neurobiology of cannabinoids
27. The role of Delta-FosB in the plasticity of the cannabinoid system
Arturo Venebra-Munoz and Sara Mejía-Chávez
28. Functional profile of synthetic cannabinoid receptor agonists:
exploring cannabinoid and non-cannabinoid targets Shivani Sachdev, Marina
Santiago and Chris Bladen
29. Linking the G protein-coupled orphan receptor GPR55 to the cannabinoid
receptors (CB1 and CB2): a new narrative Paula Morales, Raquel
Guerrero-Alba and B.A. Marichal-Cancino
30. Proteomic analysis of cannabinoids in human oligodendrocytes Valéria
Almeida
31. Cannabinoids and endocannabinoid signaling at the basal forebrain
cholinergic system Rafael Rodriguez
32. Cannabidiol (The major non-psychotropic cannabinoid in the cannabis
plant) and the PI3K/Akt pathway in the CNS Nadja Schroder
33. Effects of cannabidiol and other phytocannabinoids on ion channels
Murat Oz, Keun-Hang Susan Yang, Mohamed Mahgoub, Georg Petroianu and
Dietrich Lorke
34. Cannabis, neurodevelopment and the "two-hit hypothesis" Elisa Guma,
Lani Cupo and Mallar Chakravarty
VI. New and synthetic cannabinoids
35. Impact of tetrahydrocannabinol (THC ) and synthetic "spice"cannabinoids
on nicotine use and abuse Christie Dawn Fowler and Angeline Dukes
36. Synthetic cannabinoids: how do they compare to
DELTA9-tetrahydrocannabinol: neurological effects and beyond Chris S.
Breivogel
VII. Biomarkers, analysis and screening
37. The DSM-5 criteria of cannabis use disorder: methods and applications
Mahadev Sen, Siddharth Sarkar and Yesh Singh
38. Cannabis and clinical high risk for psychosis: monitoring and
smartphones Jean Addington
VIII. Impact on non-neurological systems
39. The impact of cannabis and cannabinoids on the skin Jane M. Grant-Kels
40. Cannabis consumption in reproduction and teratogenicity Susana Sa and
B.M. Fonseca
41. Cannabis compounds and putative cytotoxicity: profile of cancer cells
Hadar Peeri and Hinanit Koltai
IX. Treatments, strategies and resources
42. Motivational Interviewing for Cannabis Use Disorders: a narrative
review from research to practice Hugo López-Pelayo, Maria Teresa
Pons-Cabrera, Clara Oliveras Salvà and Pablo Rodrigo Guzmán Cortez
43. An Overview of Current Pharmacologic Interventions for Management of
Cannabis Withdrawal and the Evidence for Their Use David Wolinsky
44. Managing cannabinoid hyperemesis syndrome in paediatrics: A new
narrative review Justin P. Reinert
45. Gabapentinoids for the Treatment of Cannabis Use Disorder: A Focus on
Human Laboratory Research Joshua A. Lile
46. Treating psychosis in users of synthetic cannabinoids T. Klimenko and
Svetlana Shakhova
X. Resources
47. Cannabis and Web based Resources Rajkumar Rajendram
Preface
I. Setting the scene and introductory chapters
1. Metabolomics of the cannabis plant Mickel Hiebert-Giesbrecht, Claudia
Torres-Calzada and David Scott Wishart
2. The roots of Cannabis sativa: chemical and pharmacological profile L A.
Rolim
3. Cannabis related compounds in beverages and food Ilaria Di Marco
Pisciottano
4. The impact of prenatal cannabis exposure: an overview Natalia Kleinhans
5. Cannabis Genotoxicity and Cancer Incidence: Highly Concordant Synthesis
of European and USA Datasets Albert Stuart Reece and Gary K. Hulse
6. Cannabis Genotoxicity and Cancer Incidence: A Highly Concordant
Synthesis of European and USA Datasets Albert Stuart Reece and Gary K.
Hulse
7. Cannabis, Cognitive impairment and Car Crash risk U.W. Preuss
II. Cannabis usage
8. Recreational cannabis use: a French perspective of adverse effects
Emilie Bouquet, Emilie Jouanjus and Maryse Lapeyre-Mestre
9. Acute and chronic impact of cannabis on human cognition Justin Matheson
and Bernard Le Foll
10. Polydrug users, use of cannabidiol (CBD) and abuse potential/Polydrug
users, use of cannabinoids and abuse potential Kerri Alexandra Schoedel
11. Cannabis stigmas: a narrative of features Matt Reid
12. Alterations of THC and CBD ratios and impact on cognition Erica
Zamberletti
13. When cannabis is used for medicinal purposes: a focus on back pain R.
L. Price III
III. Pharmacological and Physiological Aspects
14. Cannabis, cannabinoids and receptor responses Yi Yang, Roya Derwish and
Lakshmi P. Kotra
15. Cannabidiol (CBD): abuse potential and withdrawal Kenneth W.
Sommerville and Beatrice Setnik
16. 4,5- Dihydro-1H-pyrazole/3,4-Diarylpyrazoline class of cannabinoid-1
(CB1R) receptor antagonists and their potential in medicinal applications
Malliga R. Iyer
IV. Neurobiology of cannabis
17. Neurobiology of cannabis Rohit Goyal and Deepak Kumar
18. The kynurenine pathway, neurobiology and cannabis misuse: a new
narrative Nuria Morales-Puerto and Esther O'Shea
19. Central nervous system cancers and use of cannabis and related
products: an updated narrative J. Eduardo Rodriguez Almaraz and Nicholas
Butowski
20. Chronic cannabis users: links with glutamate and resting state
connectivity S.D. Newman
21. Brain metabolic responses to cannabis use in people with multiple
sclerosis: Insights from [18F]-FDG positron emission tomography and
functional MRI Thorsten Rudroff
22. Genetic Variation and Acute Responses to Cannabis Bernard Le Foll, Zoe
Bourgault and Justin Matheson
23. Cell Signaling of the CB1 Cannabinoid Receptor via beta-arrestins,
Cannabinoid Receptor Interacting Protein (CRIP1a) and other regulatory
proteins Allyn C. Howlett
24. Cannabis and impact on memory: from in utero to adults Jennifer
Willford, Meaghan Hazelet, Mohamad Khalaifa, Natacha DeGenna and Gale A.
Richardson
25. Central CB1 receptors and age-related changes: investigating the
effects of DELTA-9-tetrahydrocannabinol Brett C. Ginsburg and Hanana
AlTfaili
26. Alcohol, cannabis and visual memory Concepcion Vinader-Caerols
V. Neurobiology of cannabinoids
27. The role of Delta-FosB in the plasticity of the cannabinoid system
Arturo Venebra-Munoz and Sara Mejía-Chávez
28. Functional profile of synthetic cannabinoid receptor agonists:
exploring cannabinoid and non-cannabinoid targets Shivani Sachdev, Marina
Santiago and Chris Bladen
29. Linking the G protein-coupled orphan receptor GPR55 to the cannabinoid
receptors (CB1 and CB2): a new narrative Paula Morales, Raquel
Guerrero-Alba and B.A. Marichal-Cancino
30. Proteomic analysis of cannabinoids in human oligodendrocytes Valéria
Almeida
31. Cannabinoids and endocannabinoid signaling at the basal forebrain
cholinergic system Rafael Rodriguez
32. Cannabidiol (The major non-psychotropic cannabinoid in the cannabis
plant) and the PI3K/Akt pathway in the CNS Nadja Schroder
33. Effects of cannabidiol and other phytocannabinoids on ion channels
Murat Oz, Keun-Hang Susan Yang, Mohamed Mahgoub, Georg Petroianu and
Dietrich Lorke
34. Cannabis, neurodevelopment and the "two-hit hypothesis" Elisa Guma,
Lani Cupo and Mallar Chakravarty
VI. New and synthetic cannabinoids
35. Impact of tetrahydrocannabinol (THC ) and synthetic "spice"cannabinoids
on nicotine use and abuse Christie Dawn Fowler and Angeline Dukes
36. Synthetic cannabinoids: how do they compare to
DELTA9-tetrahydrocannabinol: neurological effects and beyond Chris S.
Breivogel
VII. Biomarkers, analysis and screening
37. The DSM-5 criteria of cannabis use disorder: methods and applications
Mahadev Sen, Siddharth Sarkar and Yesh Singh
38. Cannabis and clinical high risk for psychosis: monitoring and
smartphones Jean Addington
VIII. Impact on non-neurological systems
39. The impact of cannabis and cannabinoids on the skin Jane M. Grant-Kels
40. Cannabis consumption in reproduction and teratogenicity Susana Sa and
B.M. Fonseca
41. Cannabis compounds and putative cytotoxicity: profile of cancer cells
Hadar Peeri and Hinanit Koltai
IX. Treatments, strategies and resources
42. Motivational Interviewing for Cannabis Use Disorders: a narrative
review from research to practice Hugo López-Pelayo, Maria Teresa
Pons-Cabrera, Clara Oliveras Salvà and Pablo Rodrigo Guzmán Cortez
43. An Overview of Current Pharmacologic Interventions for Management of
Cannabis Withdrawal and the Evidence for Their Use David Wolinsky
44. Managing cannabinoid hyperemesis syndrome in paediatrics: A new
narrative review Justin P. Reinert
45. Gabapentinoids for the Treatment of Cannabis Use Disorder: A Focus on
Human Laboratory Research Joshua A. Lile
46. Treating psychosis in users of synthetic cannabinoids T. Klimenko and
Svetlana Shakhova
X. Resources
47. Cannabis and Web based Resources Rajkumar Rajendram
I. Setting the scene and introductory chapters
1. Metabolomics of the cannabis plant Mickel Hiebert-Giesbrecht, Claudia
Torres-Calzada and David Scott Wishart
2. The roots of Cannabis sativa: chemical and pharmacological profile L A.
Rolim
3. Cannabis related compounds in beverages and food Ilaria Di Marco
Pisciottano
4. The impact of prenatal cannabis exposure: an overview Natalia Kleinhans
5. Cannabis Genotoxicity and Cancer Incidence: Highly Concordant Synthesis
of European and USA Datasets Albert Stuart Reece and Gary K. Hulse
6. Cannabis Genotoxicity and Cancer Incidence: A Highly Concordant
Synthesis of European and USA Datasets Albert Stuart Reece and Gary K.
Hulse
7. Cannabis, Cognitive impairment and Car Crash risk U.W. Preuss
II. Cannabis usage
8. Recreational cannabis use: a French perspective of adverse effects
Emilie Bouquet, Emilie Jouanjus and Maryse Lapeyre-Mestre
9. Acute and chronic impact of cannabis on human cognition Justin Matheson
and Bernard Le Foll
10. Polydrug users, use of cannabidiol (CBD) and abuse potential/Polydrug
users, use of cannabinoids and abuse potential Kerri Alexandra Schoedel
11. Cannabis stigmas: a narrative of features Matt Reid
12. Alterations of THC and CBD ratios and impact on cognition Erica
Zamberletti
13. When cannabis is used for medicinal purposes: a focus on back pain R.
L. Price III
III. Pharmacological and Physiological Aspects
14. Cannabis, cannabinoids and receptor responses Yi Yang, Roya Derwish and
Lakshmi P. Kotra
15. Cannabidiol (CBD): abuse potential and withdrawal Kenneth W.
Sommerville and Beatrice Setnik
16. 4,5- Dihydro-1H-pyrazole/3,4-Diarylpyrazoline class of cannabinoid-1
(CB1R) receptor antagonists and their potential in medicinal applications
Malliga R. Iyer
IV. Neurobiology of cannabis
17. Neurobiology of cannabis Rohit Goyal and Deepak Kumar
18. The kynurenine pathway, neurobiology and cannabis misuse: a new
narrative Nuria Morales-Puerto and Esther O'Shea
19. Central nervous system cancers and use of cannabis and related
products: an updated narrative J. Eduardo Rodriguez Almaraz and Nicholas
Butowski
20. Chronic cannabis users: links with glutamate and resting state
connectivity S.D. Newman
21. Brain metabolic responses to cannabis use in people with multiple
sclerosis: Insights from [18F]-FDG positron emission tomography and
functional MRI Thorsten Rudroff
22. Genetic Variation and Acute Responses to Cannabis Bernard Le Foll, Zoe
Bourgault and Justin Matheson
23. Cell Signaling of the CB1 Cannabinoid Receptor via beta-arrestins,
Cannabinoid Receptor Interacting Protein (CRIP1a) and other regulatory
proteins Allyn C. Howlett
24. Cannabis and impact on memory: from in utero to adults Jennifer
Willford, Meaghan Hazelet, Mohamad Khalaifa, Natacha DeGenna and Gale A.
Richardson
25. Central CB1 receptors and age-related changes: investigating the
effects of DELTA-9-tetrahydrocannabinol Brett C. Ginsburg and Hanana
AlTfaili
26. Alcohol, cannabis and visual memory Concepcion Vinader-Caerols
V. Neurobiology of cannabinoids
27. The role of Delta-FosB in the plasticity of the cannabinoid system
Arturo Venebra-Munoz and Sara Mejía-Chávez
28. Functional profile of synthetic cannabinoid receptor agonists:
exploring cannabinoid and non-cannabinoid targets Shivani Sachdev, Marina
Santiago and Chris Bladen
29. Linking the G protein-coupled orphan receptor GPR55 to the cannabinoid
receptors (CB1 and CB2): a new narrative Paula Morales, Raquel
Guerrero-Alba and B.A. Marichal-Cancino
30. Proteomic analysis of cannabinoids in human oligodendrocytes Valéria
Almeida
31. Cannabinoids and endocannabinoid signaling at the basal forebrain
cholinergic system Rafael Rodriguez
32. Cannabidiol (The major non-psychotropic cannabinoid in the cannabis
plant) and the PI3K/Akt pathway in the CNS Nadja Schroder
33. Effects of cannabidiol and other phytocannabinoids on ion channels
Murat Oz, Keun-Hang Susan Yang, Mohamed Mahgoub, Georg Petroianu and
Dietrich Lorke
34. Cannabis, neurodevelopment and the "two-hit hypothesis" Elisa Guma,
Lani Cupo and Mallar Chakravarty
VI. New and synthetic cannabinoids
35. Impact of tetrahydrocannabinol (THC ) and synthetic "spice"cannabinoids
on nicotine use and abuse Christie Dawn Fowler and Angeline Dukes
36. Synthetic cannabinoids: how do they compare to
DELTA9-tetrahydrocannabinol: neurological effects and beyond Chris S.
Breivogel
VII. Biomarkers, analysis and screening
37. The DSM-5 criteria of cannabis use disorder: methods and applications
Mahadev Sen, Siddharth Sarkar and Yesh Singh
38. Cannabis and clinical high risk for psychosis: monitoring and
smartphones Jean Addington
VIII. Impact on non-neurological systems
39. The impact of cannabis and cannabinoids on the skin Jane M. Grant-Kels
40. Cannabis consumption in reproduction and teratogenicity Susana Sa and
B.M. Fonseca
41. Cannabis compounds and putative cytotoxicity: profile of cancer cells
Hadar Peeri and Hinanit Koltai
IX. Treatments, strategies and resources
42. Motivational Interviewing for Cannabis Use Disorders: a narrative
review from research to practice Hugo López-Pelayo, Maria Teresa
Pons-Cabrera, Clara Oliveras Salvà and Pablo Rodrigo Guzmán Cortez
43. An Overview of Current Pharmacologic Interventions for Management of
Cannabis Withdrawal and the Evidence for Their Use David Wolinsky
44. Managing cannabinoid hyperemesis syndrome in paediatrics: A new
narrative review Justin P. Reinert
45. Gabapentinoids for the Treatment of Cannabis Use Disorder: A Focus on
Human Laboratory Research Joshua A. Lile
46. Treating psychosis in users of synthetic cannabinoids T. Klimenko and
Svetlana Shakhova
X. Resources
47. Cannabis and Web based Resources Rajkumar Rajendram